A “ship in a bottle” strategy to load a hydrophilic anticancer drug in porous metal organic framework nanoparticles: efficient encapsulation, matrix stabilization, and …
MR di Nunzio, V Agostoni, B Cohen… - Journal of Medicinal …, 2014 - ACS Publications
An essential challenge in the development of nanosized metal organic framework
(nanoMOF) materials in biomedicine is to develop a strategy to stabilize their …
(nanoMOF) materials in biomedicine is to develop a strategy to stabilize their …
A" ship in a bottle" strategy to load a hydrophilic anticancer drug in porous metal organic framework nanoparticles: efficient encapsulation, matrix stabilization, and …
MR di Nunzio, V Agostoni, B Cohen, R Gref… - Journal of Medicinal …, 2013 - europepmc.org
An essential challenge in the development of nanosized metal organic framework
(nanoMOF) materials in biomedicine is to develop a strategy to stabilize their …
(nanoMOF) materials in biomedicine is to develop a strategy to stabilize their …
A" ship in a bottle" strategy to load a hydrophilic anticancer drug in porous metal organic framework nanoparticles: efficient encapsulation, matrix stabilization, and …
MR di Nunzio, V Agostoni, B Cohen… - Journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
An essential challenge in the development of nanosized metal organic framework
(nanoMOF) materials in biomedicine is to develop a strategy to stabilize their …
(nanoMOF) materials in biomedicine is to develop a strategy to stabilize their …
[PDF][PDF] A “Ship in a Bottle” Strategy to Load a Hydrophilic Anticancer Drug in Porous Metal-Organic Frameworks Nanoparticles: Efficient Encapsulation, Matrix …
MR di Nunzio, V Agostoni, B Cohen, R Gref, A Douhal - pstorage-acs-6854636.s3 …
The 1 dimerization process (Scheme S1) is well known. It is accompanied by an increase
(from 6.5 to 7.1) and a decrease (from 10.7 to 10.3) in the pKa values of the 10-hydroxyl …
(from 6.5 to 7.1) and a decrease (from 10.7 to 10.3) in the pKa values of the 10-hydroxyl …